POLA PERESEPAN  OBAT ANTIHIPERTENSI PASIEN RUJUK BALIK (PRB) BPJS KESEHATAN DI APOTEK X JAKARTA TIMUR

Indrianti Poppy; Chusun; Octaviani Restu

doi:10.33759/v7i3.798

Authors

Indrianti Poppy Akademi Farmasi Bhumi Husada
Chusun Akademi Farmasi Bhumi Husada
Octaviani Restu Akademi Farmasi Bhumi Husada

DOI:

https://doi.org/10.33759/v7i3.798

Keywords:

Hipertensi, PRB,

Abstract

Hypertension is an increase in systolic blood pressure greater than or equal to (≥) 140 mmHg and/or diastolic blood pressure greater than or equal to (≥) 90 mmHg. Hypertension is one of the chronic diseases that receives services from the Referral Program (PRB). This program aims to facilitate access to health services for BPJS participants with chronic diseases. Hypertension, or high blood pressure, is one of the causes of death worldwide, with 90-95% of cases dominated by essential hypertension. This disease is considered a silent killer because people are unaware of their hypertension until they have their blood pressure checked. This study aims to determine the number and types of antihypertensive medications most frequently prescribed, identify antihypertensive medications that are and are not compliant with the National Formulary, and identify the most frequently prescribed antihypertensive drug classes for BPJS Referral Patients (PRB). This study used a quantitative descriptive method with retrospective data, namely all prescription sheets containing antihypertensive medications from October 1 to December 31, 2024. In conclusion, the results of this study indicate that hypertension patients were predominantly female (387 patients, 65.9%), and 221 patients (37.6%) were in the age group over 65 years. The most commonly prescribed antihypertensive medication was Amlodipine, with 397 prescriptions (67.6%). The most commonly prescribed antihypertensive medication class was Calcium Channel Blockers (CCBs). The compliance rate for antihypertensive medications with the National Formulary was 89.8%, while the non-compliance rate was 10.2%. This should not occur as it would impact the administrative process between pharmacies and the Social Security Administration Agency (BPJS). Therefore, ideally, 100% of antihypertensive prescriptions should be in accordance with the National Formulary.

Downloads

Download data is not yet available.

References

Akhirullah, M. M., dkk. (2023). Gambaran peresepan antihipertensi pada pasien di Apotek Mitra Banjarmasin. Jurnal Kesehatan Qomarul Huda, 11(2), 425–429.

Wulandari, A., & Ardhianingsih, V. (2022). Evaluasi pemberian dan penggunaan obat antihipertensi pada pasien lansia di Puskesmas Sukarami Palembang. Indonesian Pharmacy and Natural Medicine Journal, 5(2).

Apriliany, W., Pramukantoro, G. E., & Wijayanti, T. (2023). Analisis penggunaan obat antihipertensi pada pasien Program Rujuk Balik (PRB) di Apotek Kabupaten "A" dengan metode ATC/DDD dan DU 90%. Fakultas Farmasi, Universitas Setia Budi, 10(1), 102.

Bryniarski, P., Nazimek, K., & Marcinkiewicz, J. (2022). Immunomodulatory activity of the most commonly used antihypertensive drugs – Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. International Journal of Molecular Sciences, 23(11), 1.

Cherub, J. (2020). Tinjauan atas angiotensin receptor blocker generasi baru. Departemen Medical, PT Kalbe Farma Tbk, 47(8), 716.

Yusuf, F., dkk. (2022). Pola peresepan obat antihipertensi pada pasien BPJS Kesehatan di Apotek Kimia Farma Ahmadyani. Jurnal Kesehatan Pharmasi, 4(2), Desember 2022.

Yoga, H., dkk. (2022). Pola peresepan obat antihipertensi pada pasien hipertensi di Klinik Pratama Asty Sukoharjo. Journal of Pharmacopolium, 7(1), 10–15.

Dwi, H. (2022). Profil peresepan obat antihipertensi pada pasien hipertensi di Apotek Afena. Majalah Farmasetika, 18(3), 363–370.

Hidayatullah, A., & Rokhmiati, E. (2023). Edukasi kegawatdaruratan hipertensi dalam meningkatkan pengetahuan lansia dengan hipertensi. Jurnal Mengabdi Masyarakat Mengabdi Nusantara, 2(3), September 2023.

Hutasuhut, P. A. (2024). Pemeriksaan tekanan darah secara berkala dalam pencegahan hipertensi pada masyarakat Desa Sihopur. Jurnal Pengabdian Masyarakat (JPMA), 6(3).

James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., & Lackland, D. T. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Journal of the American Medical Association, 311(5), 507–520.

Juliana, D., & Paramita, D. D. (2023). Pola peresepan obat antihipertensi pada pasien BPJS Kesehatan di beberapa apotek daerah Bandung periode 2023.

Jurnal Riset Ilmu Farmasi dan Kesehatan, 2(5), September 2024.

Kementerian Kesehatan Republik Indonesia. (2023). Pedoman pengendalian hipertensi di fasilitas kesehatan tingkat pertama. Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2024). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/1645/2024 tentang Rujuk Balik Penyakit Kronis ke Fasilitas Kesehatan Tingkat Pertama. 14 Oktober 2024.

Lestari, T. S. (2022). Gambaran pola peresepan dan biaya obat hipertensi pada pasien BPJS program rujuk balik Apotek Kimia Farma 46 Rawa Badak Jakarta Utara. Politeknik Kesehatan Kemenkes Jakarta II, 25–36.

Nurhayati, U. A., Ariyanto, A., & Syafriakhwan, F. (2023). Hubungan usia dan jenis kelamin terhadap kejadian hipertensi. Prosiding Seminar Nasional Penelitian dan Pengabdian kepada Masyarakat, LPPM Universitas ‘Aisyiyah Yogyakarta, Juli 2023, 1–7.

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D.,

Williams, B., & Schutte, A. E. (2020). International Society of Hypertension global hypertension practice guidelines. Journal of Hypertension, 38(6), 984.

Wildayanti, dkk. (2023). Pola penggunaan obat dan biaya obat antihipertensi pada Apotek Program Rujuk Balik BPJS Kesehatan di Kabupaten Kudus. Jurnal Ilmiah Farmasi (Scientific Journal of Pharmacy), Januari–Juli 2023, 31–43.

World Health Organization. (2023). Hypertension. Retrieved May 10, 2025, from https://www.who.int/news-room/fact-sheets/detail/hypertension